A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation - Vincent, J L; Ramesh, M K; Ernest, D (Crit Care Med, 2013)
, et al.